This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Viral Infections  • World Health  • Public Health, Other  • Gastroenterology  • Liver/ Biliary Tract/ Pancreatic Diseases  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Bridget M. Kuehn

JAMA. 2009;302(18):1949-1954.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Washington, DC—More than 500 million persons worldwide are infected with hepatitis B or C virus, estimates the World Health Organization, and more than 5 million US residents have such infections, according to the US Centers for Disease Control and Prevention (CDC). Yet these infections often go undetected and untreated because patients and physicians may be unaware of who is at risk or may fail to pursue testing.

As more individuals immigrate to the United States from regions where hepatitis B virus infection is prevalent, US physicians may see higher rates of complications from such infection.

Although prevention efforts have helped dramatically reduce the incidence of hepatitis B and C viral infections in the general US population, demographic shifts are leading to growing numbers of chronically infected patients who may develop severe complications such as cirrhosis and hepatic cell carcinoma. A large cohort of individuals infected with . . . [Full Text of this Article]

COMPLICATIONS



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?